Antifungal Potential of Synthetic Peptides against <i>Cryptococcus neoformans</i>: Mechanism of Action Studies Reveal Synthetic Peptides Induce Membrane-Pore Formation, DNA Degradation, and Apoptosis
<i>Cryptococcus neoformans</i> is a human-pathogenic yeast responsible for pneumonia and meningitis, mainly in patients immunocompromised. Infections caused by <i>C. neoformans</i> are a global health concern. Synthetic antimicrobial peptides (SAMPs) have emerged as alternati...
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | <i>Cryptococcus neoformans</i> is a human-pathogenic yeast responsible for pneumonia and meningitis, mainly in patients immunocompromised. Infections caused by <i>C. neoformans</i> are a global health concern. Synthetic antimicrobial peptides (SAMPs) have emerged as alternative molecules to cope with fungal infections, including <i>C. neoformans</i>. Here, eight SAMPs were tested regarding their antifungal potential against <i>C. neoformans</i> and had their mechanisms of action elucidated by fluorescence and scanning electron microscopies. Five SAMPs showed an inhibitory effect (MIC<sub>50</sub>) on <i>C. neoformans</i> growth at low concentrations. Fluorescence microscope (FM) revealed that SAMPs induced 6-kDa pores in the <i>C. neoformans</i> membrane. Inhibitory assays in the presence of ergosterol revealed that some peptides lost their activity, suggesting interaction with it. Furthermore, FM analysis revealed that SAMPs induced caspase 3/7-mediated apoptosis and DNA degradation in <i>C. neoformans</i> cells. Scanning Electron Microscopy (SEM) analysis revealed that peptides induced many morphological alterations such as cell membrane, wall damage, and loss of internal content on <i>C. neoformans</i> cells. Our results strongly suggest synthetic peptides are potential alternative molecules to control <i>C. neoformans</i> growth and treat the cryptococcal infection. |
---|---|
Item Description: | 10.3390/pharmaceutics14081678 1999-4923 |